Xencor, Inc. (XNCR) Q4 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon. Thank you for standing by and welcome to Zencore's fourth quarter and year-end 2022 conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. Please be advised that this call is being recorded at the company's request. Now, I would like to turn the call to your speaker today, Charles Lyles, Head of Corporate Communications and Investor Relations. Sir, please go ahead. Thank you, and good afternoon. Earlier today, we issued a press release which outlines topics we plan to discuss today. The press release is available at www.zencore.com. With me on the call are Basil Zahief, President and Chief Executive Officer, Alan Yang, Chief Medical Officer, John Deserlais, Chief Scientific Officer, and John Cush, Chief Financial Officer. After we make a few comments, we will then open up the call for your questions. Before we begin, I would like to remind you that during the course of this conference call, Zencore Management may make forward-looking statements, including statements regarding the company's future financial and operating results, future market conditions, the plans and objectives of management, future operations, the company's partnering efforts, capital requirements, future product offerings, and research and development programs. These forward-looking statements are not historical facts, but rather are based on our current expectations and beliefs and are based on information currently available to us. Outcome of the events described in these forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially from the results anticipated by these forward-looking stateme...